PFE

PFIZER INC
ShareXLinkedInReddit
Sector
Health Care
Industry
Pharmaceuticals
Last price
$24.17
As of

Active signals for PFE

  • mediumEARNINGS_BEAT

    Q2-2025: Beat consensus by 32.9% — EPS $0.78 vs $0.5869 estimate

    All 2026-07-14 signals →
  • mediumEARNINGS_BEAT

    Q3-2025: Beat consensus by 36.0% — EPS $0.87 vs $0.6397 estimate

    All 2026-07-14 signals →
  • mediumEARNINGS_BEAT

    Q4-2025: Beat consensus by 14.3% — EPS $0.66 vs $0.5775 estimate

    All 2026-07-14 signals →
  • highTRIAL_TERMINATION

    Phase 3 trial terminated early — PFIZER Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin

    All 2026-07-14 signals →
  • highTRIAL_TERMINATION

    Phase 3 trial terminated early — PFIZER Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacr

    All 2026-07-14 signals →

Top institutional holders of PFE (13F)

FundMarket value% portfolioQoQ
CITADEL ADVISORS LLC$470.1M0.07%+30.4%
CITADEL ADVISORS LLC$369M0.06%,
D. E. Shaw & Co., Inc.$350.1M0.21%+265.0%
D. E. Shaw & Co., Inc.$114.3M0.06%,
RENAISSANCE TECHNOLOGIES LLC$86.5M0.11%,
D. E. Shaw & Co., Inc.$85M0.05%-23.8%
MILLENNIUM MANAGEMENT LLC$49M0.02%,
MILLENNIUM MANAGEMENT LLC$42.8M0.02%-10.8%
Point72 Asset Management, L.P.$24.2M0.03%+6.1%
Point72 Asset Management, L.P.$20.2M0.02%+314.3%
TWO SIGMA INVESTMENTS, LP$7.7M0.01%+448.9%
Point72 Asset Management, L.P.$5M0.01%,
MILLENNIUM MANAGEMENT LLC$2.7M0.00%-94.4%
TWO SIGMA INVESTMENTS, LP$1.9M0.00%,
TWO SIGMA INVESTMENTS, LP$1.2M0.00%-34.5%

Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.

Recent SEC filings, PFE

PFE mentioned in Kresmion daily briefs

Related tickers

See more PFE signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track PFE in your watchlist and get notified the moment a new signal fires.

Track PFE on Kresmion →